Note - they do not link anywhere yet.. that will be added soon.
Scroll down for inactive trials
Trials marked with a *** are duplicates

•  Vaccine: [1841] A Phase l Trial of Tumor Associated Antigen Pulsed Dendritic Cell Immunotherapy for Patients With Brain Stem Glioma and Glioblastoma
•  NCT00928226: [1939] Study of Fractionated Stereotactic Radiosurgery to Treat Large Brain Metastases
•  NCT00916409: [1924] Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)
•  NCT00912951: [1930] PHASE II, single-arm, open-label investigation of HSPPC-96 vaccine with concurrent temozolomide in patients with newly diagnosed Glioblastoma Multiforme
•  NCT00892931: [1926] Phase 2 Study of Azixa (MPC-6827) for the Treatment of Patients With Recurrent Glioblastoma Multiforme
•  NCT00880061: [1911] An Open Label Dose Escalation Safety Study of Convection-Enhanced Delivery of IL13-PE38QQR in Patients With Progressive Pediatric Diffuse Infiltrating Brainstem Glioma and Supratentorial High-Grade Glioma
•  NCT00823459: [1902] Phase II Trial of RAD001 in Patients with Recurrent Low Grade Glioma
•  NCT00747253: [1879] AutoLITT™ FIM Trial - A Prospective First-In-Man (FIM) Safety Trial of the AutoLITT Laser Treatment of Recurrent/Progressive Brain Tumors
•  * * * Duplicate ** NCT00747253: [1892] Monteris AutoLITT™ FIM Safety Trial for Recurrent/Progressive Brain Tumors
•  NCT00734682: [1903] A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas
•  NCT00730262: [1880] A Phase II Study of TLN-4601 in Patients With Glioblastoma Multiforme
•  NCT00694330: [1941] Vaccination With Lethally Irradiated Glioma Cells Mixed With GM-K562 Cells in Patients Undergoing Craniotomy For Recurrent Tumor
•  NCT00635557: [1925] Phase 1 Study of Azixa (MPC-6827) and Carboplatin in Recurrent/Relapsed Glioblastoma Multiforme
•  NCT00627224: [1845] Evaluation of Recovery From Drug-Induced Lymphopenia Using Cytomegalovirus-Specific T-Cell Adoptive Transfer [ERaDICATe]
•  NCT00626015: [1839] Chemotherapy, Radiation Therapy, and Vaccine Therapy With or Without Daclizumab in Treating Patients With Glioblastoma Multiforme That Has Been Removed by Surgery
•  NCT00615186: [1873] The GLASS-ART Trial: A Phase III Randomized Study of Neuradiab in Combination With External Beam Radiation and Temozolomide Versus External Beam Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
•  NCT00613223: [1940] Phase I Dose Escalation Trial of Vandetanib in Combo w Etoposide for Malignant Gliomas
•  NCT00612001: [1843] Phase I Study of Glioma-Associated Antigen (GAA) Peptide-Pulsed Dendritic Cell Vaccination in Malignant Glioma Patients
•  NCT00589784: [1887] Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma
•  NCT00589706: [1896] A Phase II Study of Adjuvant Use of Anti-Epidermal Growth Factor Receptor EGFR-425 (MAb-425) in High Grade Gliomas
•  NCT00586508: [1912] A Phase II Trial of Enzastaurin in Combination With Bevacizumab in Adults With Recurrent Malignant Gliomas
•  NCT00576537: [1840] Phase ll Trial of Tumor Lysate-Pulsed Dendritic Cell Immunotherapy for Patients With Atypical or Malignant, Primary or Metastatic Brain Tumors of the Central Nervous System
•  NCT00576446: [1844] A Phase l Trial of Surgical Resection With Gliadel Wafer Placement Followed by Vaccination With Dendritic Cells Pulsed With Tumor Lysate for Patients With Malignant Glioma
•  NCT00562419: [1861] Phase 2, 2-Part, Multicenter, Open-Label Study to Evaluate the Safety, Tolerability, and Efficacy of CT-322 Monotherapy and Combination Therapy With Irinotecan in Patients With Recurrent Glioblastoma Multiforme
•  * * * Duplicate ** NCT00562419: [1886] CT-322 in Treating Patients With Recurrent Glioblastoma Multiforme and Combination Therapy With Irinotecan
•  NCT00560144: [1921] Multiple Ascending Dose (MAD) Study of the IGF-1R Antagonist R1507 Administered as an Intravenous Infusion in Pediatric Patients With Advanced Solid Tumors.
•  NCT00555399: [1859] Phase I/II Adaptive Randomized Trial of Vorinostat, Isotretinoin and Carboplatin in Adults With Recurrent Glioblastoma Multiforme
•  NCT00539552: [1835] Phase II Study Of 7 Days On/7 Days Off Temozolomide In Patients With High-Grade Glioma
•  NCT00539383: [1872] A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Advanced Solid Tumors and Metastatic Brain Cancer
•  NCT00539344: [1871] A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Malignant Glioma
•  NCT00525525: [1858] A Phase II study of Bevacizumab (Avastin?) plus Temodar and Tarceva during and after Radiation Therapy in patients with newly diagnosed Glioblastoma or Gliosarcoma
•  NCT00516607: [1811] Phase I Study of Enzastaurin and Temozolomide in Patients With Gliomas
•  NCT00515086: [1794] A Pilot Multicenter Phase I/II Trial of RAD001 in Patients With Recurrent Glioblastoma Multiforme
•  NCT00509301: [1787] Open-Label Dose Confirmation and Dosimetry Study of Interstitial 131I-chTNT-1/B mAb (Cotara®) for the Treatment of Recurrent Glioblastoma Multiforme
•  NCT00504660: [1780] Combination of 6-Thioguanine, Capecitabine, Celecoxib and Temozolomide or CCNU for Recurrent Anaplastic Glioma and Glioblastoma Multiforme
•  NCT00501891: [1783] A Phase II Study of Bevacizumab (Avastin) in Combination With Metronomic Temozolomide (Temodar)for Recurrent Malignant Glioma
•  NCT00499798: [1785] Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain Tumors
•  NCT00499473: [1812] A Pharmacokinetic and Phase 2 Study of Sunitinib Malate in Recurrent Malignant Gliomas
•  NCT00498927: [1786] A Phase II Trial of Continuous Low-Dose Temozolomide for Patients With Recurrent Malignant Glioma
•  NCT00492687: [1809] A Phase II Pilot Trial of Radiation Therapy With Concurrent and Adjuvant Temozolomide, Tamoxifen and Carboplatin (T2C) in the Treatment of Patients With Primary Central Nervous System Malignant Gliomas
•  NCT00482677: [1816] A Randomized Phase III Study of Temozolomide and Short-Course Radiation Versus Short-Course Radiation Alone In The Treatment of Newly Diagnosed Glioblastoma Multiforme in Elderly Patients
•  NCT00479765: [1781] A Phase 1 / 2 Dose Escalation Study of Locally-Administered OncoGel® in Subjects With Recurrent Glioma
•  NCT00476827: [1927] A Phase II Safety and Tolerability Study of Avastin When Added to Single-Agent Chemotherapy to Treat Patient With Breast Cancer Metastatic to Brain
•  NCT00473408: [1817] The Effect of Radiotherapy and Temozolomide on the Tumor Vasculature and Stem Cells in Human High-Grade Astrocytomas
•  NCT00471653: [1826] A Pharmacokinetic and Pharmacogenomic Study of Patients With High-Grade Gliomas Receiving Daily Radiation Therapy and Temozolomide
•  NCT00463203: [1782] A Phase II Trial With Bevacizumab (Avastin) and Irinotecan (CPT-11) for Patients With Primary Brain Tumors and Progression After Standard Therapy
•  NCT00458601: [1765] Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III)
•  NCT00456612: [1825] Phase I/II Study of Fractionated CyberKnife Stereotactic Radiosurgery for High Grade Gliomas in Elderly Patients With Poor Performance Status
•  NCT00452959: [1082] A Phase 1/11 Study of Topotecan by Intracerebral Clysis for the Treatment of Recurrent Primary Malignant Brain Tumors
•  NCT00450866: [1771] Phase II Trial of Patupilone in Patients With Brain Metastases From Breast Cancer
•  NCT00445965: [1808] Phase II Study of Intrathecal I-3F8 in Patients With GD2-Expressing Central Nervous System and Leptomeningeal Neoplasms
•  NCT00441142: [1793] Phase I/II Study of ZD6474 (ZactimaTM) With Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma
•  NCT00438997: [1918] A Phase I Trial of Enzastaurin (LY317615) in Combination With Carboplatin in Adults With Recurrent Gliomas
•  NCT00437047: [1922] A Phase I Trial and Pharmacokinetic Study of Trabectedin (Yondelis®, ET-743) in Children and Adolescents With Relapsed or Refractory Solid Tumors
•  NCT00424554: [1762] A Phase II Trial to Evaluate the Effect of Low Dose Temozolomide (TMZ) for 2 Weeks (Pre-Surgery) on Brain Tumor O-6-Methylguanine-DNA Methyltransferase (MGMT) Activity in Patients With Gliomas.
•  NCT00418899: [1784] Gliogene: Brain Tumor Linkage Study
•  NCT00418327: [1757] Safety Study of Tarceva in Children With Refractory and Relapsed Malignant Brain Tumors and Newly Diagnosed Brain Stem Glioma
•  NCT00412711: [1758] Phase I/II Pazopanib Plus Lapatinib for Relapsed Malignant Glioma
•  NCT00412542: [1760] Combination Therapy With Thalidomide and CPT-11 in Patients With Recurrent Anaplastic Gliomas or Glioblastoma Multiforme
•  NCT00409214: [1818] A Phase IIa Safety and Light Dose-Escalation Study in Patients With Primary or Recurrent/High-Grade Glioma (Defined for the Purposes of the Protocol as Anaplastic Astrocytoma [AA] or Glioblastoma Multiforme [GBM]) Using the Litx™ System to Confirm the Zone of Tumor Destruction During the Intraoperative Treatment of Glioma
•  NCT00404248: [1754] Phase I/II Study of Intravenous Infusion of Tetra-o-Methyl Nordihydroguaiaretic Acid (EM-1421) in Subjects With Recurrent High Grade Glioma
•  NCT00402116: [1821] Phase 1/2 Study of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
•  NCT00401024: [1806] Determination of the In-Tumor-Concentration of Imatinib Mesylate (Gleevec) in Malignant Glioma After Oral Administration
•  NCT00400920: [1761] Clinical and Molecular-Metabolic Trial of Perifosine for Recurrent/Progressive Malignant Gliomas
•  NCT00400816: [1770] Phase II Trial of Continuous Dose Temozolomide in Patients With Newly Diagnosed Pure and Mixed Anaplastic Oligodendroglioma
•  NCT00400322: [1888] Efficacy and Safety of Valcyte® as an Add-on Therapy in Patients With Malignant Glioblastoma and CMV Infection
•  NCT00397072: [1820] Phase II Study: Systemic Treatment With iv ZK219477-Epothilone in Recurrent Glioblastoma Patients
•  NCT00394628: [1745] A Phase 2 Multicenter Study of AQ4N in Combination With Radiotherapy and Temozolomide, for Safety, Tolerability, and Activity in Subjects With Newly Diagnosed Glioblastoma Multiforme
•  NCT00393094: [1913] A Phase II Trial of Bevacizumab (avastin) and Irinotecan (CPT-11) for Patients With Recurrent High-Grade Gliomas Immediately Following Tumor Progression After Treatment With Bevacizumab Alone: A Companion Trial to NCI Study 06-C-0064 (Bevacizumab Alone for Recurrent Gliomas)
•  NCT00392327: [1779] Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor
•  NCT00390299: [1744] Phase I Study of Intratumoral and/or Resection Cavity Administration of Recombinant Measles Virus Encoding Human Carcinoembryonic Antigen in Patients With Recurrent Glioblastoma Multiforme
•  NCT00389090: [1775] A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic Glioma
•  NCT00381797: [1893] Bevacizumab (Avastin) and Irinotecan (CPT-11) in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma
•  NCT00379132 : [1740] A Phase I Imaging and Safety Study of Intravenous 131-I-TM-601 Labelled Chlorotoxin In Patients with Recurrent or Refractory Somatic and/or Cereberal Metastatic Solid Tumors
•  NCT00379080: [1766] A Feasibility Assessment and a Phase I/II Trial of MLN518 (Tandutinib) for Treatment of Patients with Recurrent Glioblastoma
•  NCT00376818: [1767] Evaluation of a Stress Reduction Program in Patients With Malignant Brain Tumors and Their Family Caregivers
•  NCT00365222: [1788] Phase II Study of Dose Intensive Temozolomide (Temodar) in Elderly Adults With Newly Diagnosed Glioblastoma
•  NCT00360854: [1759] Erlotinib (Tarceva) Alone or in Combination With Radiation Therapy in Treating Young Patients With Refractory or Relapsed Malignant Brain Tumors or Newly Diagnosed Brain Stem Glioma
•  NCT00354068: [1804] A Phase I Study of Imatinib Mesylate (Gleevec) in Combination With Temozolomide (Temodar) in Patients With Malignant Glioma
•  NCT00350727: [1769] Phase I and II, Open-Label, Multi-Center Trials of Pazopanib in Combination With Lapatinib in Adult Patients With Relapsed Malignant Glioma
•  NCT00346203: [1746] RTA 744 in Treating Patients With Recurrent or Refractory Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Anaplastic Mixed Oligoastrocytoma, Glioblastoma Multiforme, or Gliosarcoma
•  NCT00337207: [1803] A Phase II Safety Study of Bevacizumab in Patients With Multiple Recurrent or Progressive Malignant Gliomas
•  NCT00335764: [1805] Phase I/II Studies of BAY 43-9006 (Sorafenib) in Combination With OSI-774 (Erlotinib), R115777 (Tipifarnib) or CCI-779 (Temsirolimus) in Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
•  NCT00331526: [1798] Phase II Trial of Intralesional Adoptive Cellular Therapy of Glioblastoma With Interleukin-2-Stimulated Lymphocytes
•  NCT00329719: [1720] Phase I/II Study of Sorafenib and Temsirolimus (CCI-779) in Patients With Recurrent Glioblastoma
•  NCT00323115: [1722] Phase II Feasibility Study of Dendritic Cell Vaccination for Newly Diagnosed Glioblastoma Multiforme
•  NCT00316849: [1735] Phase I Study of Temsirolimus and Concurrent Chemoradiotherapy Comprising Temozolomide and Radiotherapy Followed By Adjuvant Temsirolimus and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
•  NCT00314808: [1703] A Pilot Study of Dronabinol for the treatment of nausea,vomiting and appetite loss in Adult Patients With Primary Gliomas
•  NCT00313729: [1704] Phase II Study of Temozolomide in Patients With Supratentorial Low-Grade Glioma
•  NCT00313664: [1914] A Phase II Clinical Trial of the Histone Deacetylase Inhibitor Valproic Acid in Combination With Temodar and Radiation Therapy in Patients With High Grade Gliomas
•  NCT00312728: [1730] A Study of Bevacizumab in Combination With First- or Second-Line Therapy in Subjects With Brain Metastases Due to Non-Squamous NSCLC
•  NCT00311857: [1710] Treatment of Primary Glioblastoma Multiforme With Cetuximab (Erbitux), Radiotherapy and Temozolomide (GERT) – Phase I/II Trial
•  NCT00311558: [1768] Phase I Evaluation of Sodium Stibogluconate in Combination With Interferon a-2b for Solid Tumors, Lymphoma or Myeloma
•  NCT00305864: [1723] Phase I/II Study of Motexafin Gadolinium Given Concurrently With Temozolomide and Fractionated Radiotherapy in Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme
•  NCT00304044: [1920] AIDS-Related Primary Central Nervous System Lymphoma: A Phase II Pilot Study of High-Dose Intravenous Methotrexate With Rituximab, Leucovorin Rescue and Highly Active Antiretroviral Therapy
•  NCT00304031: [1714] Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma
•  NCT00301418: [1695] Phase I/II Trial of Oral Erlotinib (Tarceva, OSI-774) for Treatment of Relapsed/Refractory Glioblastoma Multiforme and Anaplastic Astrocytoma
•  NCT00293566: [1917] A Phase I/II Trial of ZD6474 for Patients With Recurrent High-Grade and Progressive Low-Grade Gliomas
•  NCT00293423: [1688] Phase I/II Study of GP96 Heat Shock Protein-Peptide Complex Vaccine in Patients With Recurrent or Progressive High-Grade Glioma
•  NCT00290797: [1915] Phase II Trial of Bevacizumab (Avastin)for Patients With Recurrent High-Grade Glioma
•  NCT00283569: [1718] Genetic Epidemiology of Adult-Onset Glioma
•  NCT00283556: [1727] Phase I/II Study of High Dose Irinotecan (Camptosar, CPT-11) in Patients With Recurrent Unresectable Malignant Glioma on Steroids/Anti-Epileptics
•  NCT00283543: [1716] A Phase II Study of Radiation With Concomitant and Then Sequential Temozolomide in Patients With Newly Diagnosed Supratentorial Malignant Glioma Who Have Undergone Surgery With Gliadel Wafer Insertion
•  NCT00280475: [1685] Randomized Phase III Trial of Postoperative Whole Brain Radiation Therapy Compared With Salvage Stereotactic Radiosurgery in Patients With One to Four Brain Metastasis: Japan Clinical Oncology Group Study (JCOG 0504)
•  NCT00276783: [1693] Phase II Study of Pemetrexed Disodium (Alimta) in Patients With Recurrent Malignant Gliomas, Primary CNS Lymphoma, or Brain Metastases
•  NCT00276770: [1690] Pilot Study of the Safety and Accuracy of Fluorothymidine F 18 Positron Emission Tomography in Detecting Recurrent Disease in Patients With Gliomas
•  NCT00275002: [1700] Phase II Study of O6-Benzylguanine and Temozolomide (Temodar) in Pediatric Patients With Recurrent or Progressive High-Grade Gliomas or Brain Stem Tumors
•  NCT00272870: [1702] A Pilot Study of Temozolomide and 06Benzylguanine for Treatment of Newly Diagnosed High Grade Glioma, Using Autologous Peripheral Blood Stem Cells Genetically Modified for Chemoprotection
•  NCT00268385: [1679] A Phase I Study of Vorinostat [Suberoylanilide Hydroxamic Acid (SAHA)] in Combination with Temozolomide in Patients with Malignant Gliomas
•  NCT00253721: [1639] Melphalan and Mannitol in Treating Patients With Central Nervous System Tumors
•  NCT00253474: [936] A Phase I/II Trial of PEG-Interferon Alfa-2B (PEG-Intron) for Plexiform Neurofibromas (NF1 patients)
•  NCT00251797: [1705] A Phase I Trial Using Combination Irinotecan (CPT-11) and Thalidomide for Recurrent CNS Tumors
•  NCT00250887: [880] Pre- and Postoperative Use of ZD1839(Iressa) in Recurrent Glioblastoma, Including Translational Research
•  NCT00250211: [1655] Multimodality Functional Imaging (MRS and Tumor Perfusion) Predicts Tumor Migration, Invasiveness, and Patterns of Failure of Human Gliobastoma Treated With Concurrent Radiation Therapy and Temozolomide
•  NCT00248534: [1717] Phase II Study of Rituximab, Temozolomide, and Methylprednisolone in Patients With Recurrent Primary CNS Non-Hodgkin`s Lymphoma
•  NCT00247403: [1681] Phase I Clinical Trial: 2DG (2-Deoxyglucose ) + Stereotactic Radiosurgery (SRS) Protocol for Treatment of Intracranial Metastases
•  NCT00243022: [1633] Boswellia Serrata Combined With a Low-Fat, Vegan Diet or a Standard Diet Alone in Treating Patients Who Have Undergone Surgery and Radiation Therapy for Newly Diagnosed Glioblastoma Multiforme
•  NCT00238303: [1643] Vorinostat in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme
•  NCT00238173: [1660] Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors
•  NCT00226655: [1665] NTI 0501: An Open-Labeled, Extended-Use of Human Corticotropin-Releasing Factor (hCRF) (Xerecept) Intended for Patients Who Participate in Dexamethasone-Sparing Studies NTI 0302 or NTI 0303
•  NCT00213278: [1713] Phase 2 Study of Vinblastine in Children With Recurrent or Refractory Low Grade Glioma
•  NCT00209989: [1646] Phase II Trial to Assess the Radiosensitizing Effect of ZARNESTRA in Patients With Glioblastoma Multiforme
•  NCT00209248: [851] PS-341 With Oral Temozolomide in Patients With Advanced Refractory Solid Tumors or Melanoma
•  NCT00207350: [1661] Neurosurgical Use of Interstitial Laser Therapy (ILT)
•  NCT00200161: [796] Concurrent Temozolomide and Radiotherapy Followed By Dose Dense Versus Metronomic Temozolomide and Maintenance Cis-Retinoic Acid For Patients With Newly Diagnosed Glioblastoma And Other Malignant Gliomas
•  NCT00194766: [447] Continuous Temozolomide (SCH 52365) in Patients with Advanced or Metastatic Soft Tissue Sarcoma or Metastatic Breast Cancer, Phase II
•  NCT00190424: [1630] Randomized Phase 2 with CpG-ODN in Malignant Glioblastoma
•  NCT00187642: [747] A Phase II Study of Temozolomide (temodar) in the Treatment of Adult Patients with Supratentorial Low Grade Glioma
•  NCT00179907: [1648] A Phase I/II Study of Reirradiation for Recurrent Pediatric Brain and Spinal Cord Tumors and Primary Glioblastoma Multiforme Using the Photon Radiosurgery System
•  NCT00179881: [715] Thalomid™ and Carboplatin for the Treatment of Pediatric Brain Stem Glioma
•  NCT00165477: [1637] Study of Lenalidomide and XRT in Patients with Newly Diagnosed Glioblastoma Multiforme
•  NCT00165360: [1172] Phase II Study of Prolonged Daily temozolomide for Low-Grade Glioma
•  NCT00135876: [1023] A trial of Dalteparin low molecular weight heparin for primary prophylaxis of venous thromboembolism in brain tumor patients.
•  NCT00132158: [1653] ZD1839 and Oral Irinotecan in Treating Young Patients with Refractory Solid Tumors
•  NCT00128986: [1707] A Phase I Study of Tomotherapy in Patients With Benign Brain Tumour
•  NCT00125710: [1709] Comparative 2-D Tumor Analysis in Familial Gliomas
•  NCT00124657: [1536] Erlotinib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Glioma
•  NCT00115440: [1629] Boron Neutron Capture Therapy (BNCT) to Treat Anaplastic Astrocytoma or Glioblastoma That Has Progressed Following Radiotherapy
•  NCT00114140: [1580] A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas
•  NCT00112762: [1916] Phase II Trial of Tamoxifen and Bortezomib in Patients With Recurrent High-Grade Gliomas
•  NCT00112736: [1548] NABTC 04-02: Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma
•  NCT00112502: [955] Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme
•  NCT00109798: [1510] Phase 2 Trial of Salvage Chemotherapy with Temozolomide in Combination with Topotecan for Primary CNS Lymphoma.
•  NCT00107471: [1729] Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma
•  NCT00107458: [1593] Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors
•  NCT00107367: [1596] A Phase I/II Study Utilizing the Zeiss INTRABEAM System for the Treatment of a Resected Solitary Brain Metastasis
•  NCT00107185: [1842] Phase I Dose Escalation Study of Autologous Tumor Lysate-Pulsed Dendritic Cell Immunotherapy for Malignant Gliomas in Pediatric Patients
•  NCT00104091: [1542] A Multicenter Phase II Study of TP-38 in Those Patients With Glioblastoma Multiforme Who Have Recurred or Progressed After Previous Resection and Radiation Therapy and Are Scheduled for Gross Total Resection
•  NCT00100880: [1719] Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors
•  NCT00100802: [1680] Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas
•  NCT00098865: [1592] Thalidomide and Temozolomide in Treating Young Patients With Relapsed or Progressive Brain Tumors or Recurrent Neuroblastoma
•  NCT00098761: [1591] VNP40101M in Treating Young Patients With Recurrent, Progressive, or Refractory Primary Brain Tumors
•  NCT00098605: [1608] Lapatinib in Treating Brain Metastases in Patients With Stage IV Breast Cancer and Brain Metastases
•  NCT00096265: [1604] Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer
•  NCT00096252: [969] Phase II Study of Brachytherapy Using the Intracavity GliaSite® Radiation Therapy System (RTS) With or Without Stereotactic Radiosurgery in Patients With Newly Diagnosed Supratentorial Brain Metastases
•  NCT00095940: [1509] A Phase I, Molecular Biology, and Phase II Study of Lapatinib (GW572016) in Pediatric Patients with Recurrent or Refractory Medulloblastoma, Malignant Glioma or Ependymoma
•  NCT00095771: [1568] Arsenic Trioxide and Radiation Therapy in Treating Young Patients With Newly Diagnosed Gliomas (Brainstem glioma, glioblastoma multiforme, gliosarcoma, anaplastic astrocytoma)
•  NCT00089245: [1601] Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal Cancer
•  NCT00087230: [1354] Intratumoral Transferrin-CRM107 (Transmid) Compared With Best Standard Chemotherapy in Treating Patients With Progressive and/or Recurrent Glioblastoma Multiforme
•  NCT00085254: [1168] Cilengitide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
•  NCT00085215: [1324] Phase I/II, two-arm, multicenter, dose escalation study of Oral AEE788 administered on a continuous once daily dosing schedule in adult patients with recurrent or relapsing glioblastoma.
•  NCT00085202: [1706] Phase 3 study: Radiation Therapy and Combination Chemotherapy Followed by Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor
•  NCT00084838: [1089] Phase II Study of Multi-Agent Intrathecal and Systemic Chemotherapy With Radiotherapy in Children With Newly Diagnosed Central Nervous System Atypical Teratoid/Rhabdoid Tumors
•  NCT00083304: [1176] Enrich Trial: Phase 3, Randomized, Open-label, Comparative Study of Standard Whole Brain Radiation Therapy with Supplemental Oxygen, with or without Concurrent RSR13 (efaproxiral), in Women with Brain Metastases from Breast Cancer
•  NCT00083096: [1656] Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial Gliomas
•  NCT00082992: [1483] Talampanel, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
•  NCT00080938: [1603] Temozolomide and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastasis Secondary to Non-Small Cell Lung Cancer
•  NCT00079339: [1618] Tipifarnib and Radiation Therapy in Treating Young Patients with Brainstem Glioma
•  NCT00077207: [1578] Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma
•  NCT00076856: [882] A Randomized, Open-Label Phase 3 Study of Temozolomide Added to Whole Brain Radiation Therapy Versus Whole Brain Radiation Therapy Alone for the Treatment of Brain Metastasis From Non-Small Cell Lung Cancer
•  NCT00075387: [504] Phase II Randomized Study of Intra-Arterial Carboplatin, Cyclophosphamide, and Etoposide or Etoposide Phosphate With or Without Delayed High-Dose Sodium Thiosulfate in Patients With High-Grade Glioma
•  NCT00075166: [1595] Surgery Versus Radiosurgery to Treat Metastatic Brain Tumors
•  NCT00074334: [1577] TP-38 Toxin in Treating Young Patients With Recurrent or Progressive Supratentorial High-Grade Glioma(or Glioblastoma multiforme)
•  NCT00074178 : [757] Chemotherapy for Non-Hodgkin`s Lymphoma Involving the Central Nervous System
•  NCT00074178: [716] Methotrexate, Cyclophosphamide, and Etoposide Phosphate Given With Osmotic Blood-Brain Barrier Disruption Plus Dexamethasone and Cytarabine in Treating Patients With Primary CNS Lymphoma
•  NCT00070096: [1597] Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors
•  NCT00068510: [1131] Phase I Study of Immunization With Autologous Tumor Lysate-Pulsed Dendritic Cells in Patients With Malignant Gliomas (Vaccine Therapy in Treating Patients With Malignant Glioma)
•  * * * Duplicate ** NCT00068510: [578] Phase I Dose Escalation Study of Autologous Antigen-Pulsed Dendritic Cell Immunotherapy for Malignant Gliomas (e.g. Glioblastoma Multiforme, Anaplastic Astrocytoma)
•  NCT00066248: [1606] Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment
•  NCT00060879: [1045] Phase I Study of Tipifarnib and Radiotherapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
•  NCT00058123: [1014] Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma
•  NCT00054496: [1482] Phase II Study of Erlotinib in Patients With Recurrent or Progressive Glioblastoma Multiforme
•  NCT00053963: [1589] FR901228 in Treating Children with Refractory or Recurrent Solid Tumors or Leukemia
•  NCT00052650: [1494] PEG-Interferon alfa-2b With or Without Thalidomide in Treating Patients With Recurrent High-Grade Gliomas
•  * * * Duplicate ** NCT00052650: [973] A Randomized Phase II Study of Peg-Interferon Alpha-2B (Peg-Intron) Alone or in Combination with Thalidomide in Adults with Recurrent High-Grade Gliomas
•  NCT00052455: [1554] Temozolomide Compared to Procarbazine, Lomustine, and Vincristine in Treating Patients With Recurrent Malignant Glioma
•  NCT00052286: [1721] Pilot Randomized Study of Modafinil for Treatment of Fatigue and Neurobehavioral Dysfunction in Patients With Primary Brain Tumors
•  NCT00049361: [1609] Radiation Therapy Plus Thalidomide and Temozolomide in Treating Patients With Newly Diagnosed Brain Metastases
•  NCT00049127: [1347] Phase I/II Trial of Imatinib Mesylate; (Gleevec; ST1571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
•  * * * Duplicate ** NCT00049127: [1624] Phase I/II Trial of Imatinib Mesylate; (Gleevec; ST1571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
•  NCT00049023: [1598] Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors
•  NCT00047320: [618] Phase II Study of Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiotherapy With or Without Peripheral Blood Stem Cell Rescue in Patients With Intracranial Non-Germinomatous Germ Cell Tumors
•  NCT00045968: [1750] Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer
•  NCT00042991: [1507] Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas
•  NCT00042367: [749] Pilot Study of Systemic and Intrathecal Chemotherapy Followed by Conformal Radiation for Infants with Brain Tumors
•  NCT00041145: [1919] A Phase II Study of Pegylated Interferon Alfa-2b (PEG-INTRON) in Children With Diffuse Pontine Gliomas
•  NCT00039494: [1544] Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors
•  NCT00036569: [967] A Phase II Study of Pegylated Interferon Alfa-2b (Peg-Intron`) in Children with Diffuse Pontine Gliomas
•  NCT00032903: [1095] Oral ST 1481 in adults with Malignant Glioma: a Phase I-II Clinical Trial
•  NCT00031590: [804] Reduced Dose Craniospinal Radiation (1800 cGy) and Chemotherapy in children with newly-diagnosed standard-risk posterior fossa primitive neuro-ectodermal tumor (PNET/medulloblastoma )
•  NCT00031577: [787] Phase I trial to study the effectiveness of combining paclitaxel with radiation therapy in treating children who have newly diagnosed brain stem glioma.
•  NCT00027846: [1508] Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma
•  NCT00026494: [1612] Temozolomide and Vinorelbine in Treating Patients With Recurrent Brain Metastases
•  NCT00008008: [1569] Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Malignant Glioma (Glioblastoma multiforme, Gliosarcoma, Anaplastic astrocytoma, PNET, Oligodendroglioma)
•  NCT00007982: [1582] Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Central Nervous System Cancer
•  NCT00005952: [1588] Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors
•  NCT00005812: [867] Temozolomide in Treating Patients With Leptomeningeal Metastases From a Solid Tumor or Lymphoma
•  NCT00004259: [1093] Phase III Randomized Study of Radiotherapy Combined With Temozolomide Versus Carmustine in Patients With Anaplastic Astrocytoma or Mixed Gliomas
•  NCT00004129: [1490] Phosphorus 32 in Treating Patients With Glioblastoma Multiforme
•  NCT00003514: [1599] Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy
•  NCT00003476: [1587] Antineoplaston Therapy in Treating Children With Primary Malignant Brain Tumors
•  NCT00003475: [1563] Antineoplaston Therapy in Treating Patients With Primary Malignant Brain Tumors
•  NCT00003466: [1586] Temozolomide in Treating Patients With Progressive Low-Grade Glioma
•  NCT00003458: [1585] Antineoplaston Therapy in Treating Children With Brain Tumors
•  NCT00003457: [1562] Antineoplaston Therapy in Treating Patients With Brain Tumors
•  NCT00003096: [353] Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study)
•  NCT00002899: [1133] Whole Brain Radiation following surgical resection in patients with newly diagnosed brain metastases: A Phase III prospective randomized trial
•  NCT00002899 : [1026] No Radiotherapy versus Whole Brain Radiotherapy for 1 to 3 Brain Metastases from Solid Tumor after Surgical Resection or Radiosurgery. A Randomized Phase III Trial.
•  NCT00002647: [381] Phase I study of Photodynamic Therapy with porfimer sodium for refractory brain tumors
•  NCT00001635: [1615] A Phase II Study of HLA-Matched Peripheral Blood Stem Cell Transplantation for Metastatic Renal Cell Carcinoma as Adoptive Allogeneic Immunotherapy
•  NCT00001574: [1605] A Pilot Study of 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Pediatric Patients with Primary and Metastatic Brain Tumors
•  NCT0000067232: [1367] Boron Neutron Capture Therapy Following Surgery in Treating Patients With Glioblastoma Multiforme Removed During Surgery
•  724770: [1929] ABTC07-01-Phase I Trial of Aflibercept (VEGF Trap) with Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients with Malignant Glioma
•  00795457: [1895] A Pilot Study to Evaluate the Effects of Vaccinations with HLA-A2-Restricted Glioma Antigen-Peptides in Combination with Poly-ICLC for Adults with High-Risk WHO Grade II Astrocytomas and Oligo-Astrocytomas
•  00777153: [1907] Phase III Randomized, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Subjects to Compare the Efficacy of AZD2171 [RECENTIN] Monotherapy and the Combination of AZD2171 with Lomustine to the Efficacy of Lomustine Alone

Inactive Trials

Note - these mighe be duplicates, or closed trials

•  NCT00481455: [1795] A Single-Center, Open-Label, Phase II, Safety and Efficacy Study of Panzem Nanocrystal Colloidal Dispersion Administered Orally in Combination With Protracted Oral Fixed-Dose Temozolomide to Patients With Recurrent Glioblastoma Multiforme
•  NCT00463073: [1810] A Phase II Trial With Cetuximab (Erbitux), Bevacizumab (Avastin) and Irinotecan (CPT-11) for Patients With Malignant Glioblastomas and Progression After Radiation Therapy and Temozolamide
•  NCT00459381: [1796] Phase I and II, Open-Label, Multi-Center Trials of Pazopanib in Combination with Lapatinib in Adult Patients with Relapsed Malignant Glioma
•  NCT00445588: [1823] A Phase II Trial of Erlotinib (OSI-774) and Sorafenib (BAY 43-9006) for Patients With Progression or Recurrent Glioblastoma Multiforme
•  NCT00424060: [1807] Phase II Study of ZK 219477 in Patients With Recurrent Glioblastoma
•  NCT00423735: [1797] Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme
•  NCT00392171: [1802] The Temozolomide RESCUE Study: A Phase II Trial of Continuous (28/28) Dose-Intense Temozolomide (CDIT) Chemotherapy After Progression on Conventional 5/28 Day Temozolomide in Patients With Recurrent Malignant Glioma
•  NCT00390403: [1791] A Phase I, Open Label Study of AT-101 (Gossypol) Plus Radiotherapy and Temozolomide and of AT-101 Plus Adjuvant Temozolomide for Patients With Newly-Diagnosed Glioblastoma Multiforme
•  NCT00387933: [1819] Phase I Dose Escalation of Gleevec in Combination With PTK787/ZK 222584 (PTK/ZK) Plus Hydroxyurea
•  NCT00385853: [1792] A Phase I Study of PRK787/ZK 222584 in Combination With Daily Temozolomide and Radiation in Patients With Newly Diagnosed Glioblastoma
•  NCT00376103: [1764] A Phase I/II Trial of Maximal Resection, Local Radiation Boost With Concomitant Temozolomide, Followed by External Radiation Therapy With Concomitant Temozolomide for the Treatment of Newly Diagnosed Glioblastoma Multiforme
•  NCT00362921: [1267] Phase II trial of Gliadel plus O6-Benzylguanine for patients with recurrent glioblastoma multiforme.
•  NCT00352521: [1814] Dynamic Contrast-Enhanced Magnetic Resonance Imaging With Bevacizumab (Avastin) in Combination With Irinotecan (CPT-11) for Malignant Gliomas
•  NCT00306618: [1712] A Single-Center, Open-Label, Phase II, Safety, Pharmacokinetic and Efficacy of Panzem Nanocrystal Colloidal Dispersion Administered Orally to Patients With Recurrent Glioblastoma Multiforme
•  NCT00305656: [1694] Phase II Study of AZD2171 in Patients With Recurrent Glioblastoma Multiforme
•  NCT00292149: [1696] Phase II Study Evaluating the Efficacy of Imatinib Mesylate (Gleevec) in Combination With Hydroxyurea in Patients With Recurrent Glioblastoma Multiforme (GBM) Receiving Enzyme-Inducing Anticonvulsant Drugs
•  NCT00290771: [1687] Efficacy and Safety of Imatinib Mesylate (Gleevec) Plus Hydroxyurea (HU) in Patients With Recurrent Glioblastoma Multiforme (GBM)
•  NCT00275067: [1684] Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By Surgery
•  NCT00268359: [1689] Phase II Study of Bevacizumab (Avastin) and Irinotecan Hydrochloride (CPT-11) in Patients With Recurrent or Refractory Grade 3 or 4 Malignant Gliomas
•  NCT00267592: [1672] Phase II Trial of Talampanel in Conjunction With Radiation Therapy With Recurrent and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
•  NCT00253448: [1644] Stereotactic Radiosurgery and Radiation Therapy in Treating Patients With Glioblastoma Multiforme
•  NCT00250887: [1638] Pre- and Postoperative Use of ZD1839(Iressa) in Recurrent Glioblastoma, Including Translational Research
•  NCT00238277: [1642] Temozolomide During and After Radiation Therapy in Treating Patients Who Have Undergone Previous Surgery and Placement of Gliadel Wafers for Newly Diagnosed Glioblastoma Multiforme
•  NCT00227032: [1256] Phase II, multicenter, open-label trial of the safety and efficacy of Tarceva in patients with first relapse of grade IV glioma (glioblastoma multiforme)
•  * * * Duplicate ** NCT00227032: [1635] Safety and Pharmacokinetics Study of Erlotinib (Tarceva) to Treat Patients with Recurrent Glioblastoma Multiforme.
•  NCT00179803: [1649] Phase II Prospective Study of Sequential Myeloablative Chemotherapy with Stem Cell Rescue for the Treatment of Selected High Risk CNS Tumors and Recurrent CNS Tumors.
•  NCT00171938: [1645] Open-Label Trial of Imatinib Mesylate (Gleevec) in Patients With Unresectable Recurrent Glioblastoma Multiforme Expressing PDGFR (Platelet Derived Growth Factor Receptors)
•  NCT00157703: [1658] A Staged Phase 1 Study of the Treatment of Malignant Glioma with G207, a Genetically Engineered HSV-1, Followed by Radiation Therapy
•  NCT00154375: [1647] Phase III Study of Imatinib Mesylate (Gleevec) in Combination with Hydroxyurea Versus Hydroxyurea Alone as an Oral Therapy in Patients with Temozolomide Resistant Progressive Glioblastoma
•  NCT00147056: [1654] A Feasibility Study to Evaluate the Safety and Feasibility of Transcranial MRI-Guided Focused Ultrasound Surgery in the Treatment of Brain Lesions
•  NCT00128700: [1641] Temozolomide and Radiation Therapy With or Without Vatalanib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
•  NCT00128635: [1636] Iodine I 131 Monoclonal Antibody TNT-1/B (131I MOAB TNT-1/B), in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme
•  NCT00120939: [1657] Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer
•  NCT00119288: [1632] Cilengitide in Treating Patients With Recurrent Glioblastoma Multiforme
•  NCT00118222: [382] Photodynamic Therapy Using Porfimer Sodium in Treating Patients Who Are Undergoing Surgery for Recurrent Malignant Astrocytoma
•  NCT00116376: [1543] Study of AEE788 in Patients with Recurrent/Relapse Glioblastoma Multiforme (GBM)
•  NCT00115453: [1628] Boron Neutron Capture Therapy (BNCT) as Treatment of Glioblastoma
•  NCT00114309: [1739] A Phase II Open-Label, Multiple-Dose Study of Intracavitary Administered 131I-TM-601 in Adult Patients with Recurrent High-Grade Glioma
•  NCT00112866: [1631] Cilengitide in Treating Patients Who Are Undergoing Surgery for Recurrent or Progressive Glioblastoma Multiforme
•  NCT00112619: [1594] Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors
•  NCT00110032: [1584] Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors
•  NCT00107237: [1540] AEE788 and Everolimus in Treating Patients With Recurrent or Relapsed Glioblastoma Multiforme
•  NCT00105014: [1567] Interleukin-13 PE38QQR Immunotoxin and Radiation Therapy With or Without Temozolomide in Treating Patients Who Have Undergone Surgery for Newly Diagnosed Malignant Glioma
•  NCT00103129: [1541] NABTC 04-01: Lapatinib in Treating Patients Who Are Undergoing Surgery for Recurrent Progressive Glioblastoma Multiforme or Gliosarcoma
•  NCT00103038: [1573] Magnetic Resonance Imaging Using Ferumoxytol in Patients With Primary Brain Cancer or Brain Metastases From Lung or Breast Cancer
•  NCT00102648: [1486] Phase I Study of Sarasar and Temodar in Patients with Recurrent or Temodar-Refractory Glioblastoma Multiforme
•  * * * Duplicate ** NCT00102648: [726] A phase II study of temozolomide (continuous low dose) for the treatment of recurrent malignant glioma
•  NCT00099125: [1546] Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
•  NCT00099060: [1488] Lapatinib in Treating Patients With Recurrent Glioblastoma Multiforme
•  NCT00095940: [1590] Lapatinib in Treating Young Patients With Recurrent or Refractory CNS Tumors
•  NCT00093964: [1477] Cilengitide (EMD 121974) for Recurrent Glioblastoma Multiforme (Brain Tumor)
•  NCT00093613: [1559] Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma
•  NCT00090597: [1122] A Complementary Trial of an Immunotherapy Vaccine Against Tumor-Specific EGFRvIII
•  * * * Duplicate ** NCT00090597: [1259] A Complementary Trial of an Immunotherapy Vaccine Against Tumor-Specific EGFRvIII
•  NCT00089245: [868] Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal Cancer
•  NCT00085735: [28] Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma
•  NCT00085566: [1485] Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate Cancer
•  NCT00085540: [1558] FR901228 in Treating Patients With Recurrent High-Grade Gliomas
•  NCT00082797: [1538] High-Dose Methotrexate and Leucovorin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
•  NCT00080054: [1498] A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas
•  * * * Duplicate ** NCT00080054: [881] A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas
•  NCT00079339: [1233] PBTC014: Phase I/II Trial of R115777 and XRT in Pediatric Patients with Newly Diagnosed Non-Disseminated Intrinsic Diffuse Brainstem Gliomas
•  NCT00079092: [1496] Thalidomide and Procarbazine in Treating Patients With Recurrent or Progressive Malignant Glioma
•  NCT00075894: [456] Phase I Study of Alanosine (SDX-102) in Patients With Methylthioadenosine Phosphorylase (MTAP)-Deficient High-Grade Progressive or Recurrent Malignant Gliomas
•  NCT00075491: [1056] Phase II evaluation with correlative studies of Fenretinide (NSC 374551 - 4HPR) as a single agent in the treatment of adult patients with recurrent glioblastoma multiforme
•  NCT00075387: [1495] Carboplatin, Cyclophosphamide, and Etoposide or Etoposide Phosphate With or Without Sodium Thiosulfate in Treating Patients With High-Grade Glioma
•  NCT00074646: [1497] Phase I trial of CC-8490 for the treatment of subjects with recurrent/refractory high-grade gliomas
•  NCT00072163: [1078] Phase II Study of Daily Low Dose Thalidomide and Temodar in Multiple Brain Metastases
•  NCT00070525: [1576] Tipifarnib in Treating Young Patients With Recurrent or Progressive High-Grade Glioma, Medulloblastoma, Primitive Neuroectodermal Tumor, or Brain Stem Glioma
•  * * * Duplicate ** NCT00070525: [1088] A Phase II Study of R115777 (ZARNESTRA) (NSC# 702818, IND# 58359) in Children with Recurrent or Progressive High Grade Glioma, Medulloblastoma/PNET or Brainstem Glioma
•  NCT00070161: [1571] Donepezil or EGb761 in Improving Neurocognitive Function in Patients Who Have Previously Undergone Radiation Therapy for Primary Brain Tumor or Brain Metastases
•  NCT00068770: [1353] Celecoxib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Who Are Receiving Anticonvulsant Drugs and Undergoing Radiation Therapy
•  NCT00068666: [1616] Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
•  NCT00062881: [1010] Intrathecal mafosfamide for patients with neoplastic meningitis (carcinomatous or lymphomatous meningitis)
•  NCT00058097: [1097] Phase II Study of Tipifarnib (R115777) and Radiotherapy in Patients With Newly Diagnosed Glioblastoma Multiforme
•  * * * Duplicate ** NCT00058097: [1070] Phase II Study of Tipifarnib (R115777) for the Treatment of Adults with Newly Diagnosed Glioblastoma Multiforme
•  NCT00054496: [982] Erlotinib in Treating Patients With Recurrent or Progressive Glioblastoma Multiforme
•  NCT00053183: [1067] NABTT 2105 Phase I Brachytherapy Dose Escalation Using the GliaSite RTS in Newly Diagnosed Glioblastoma Multiforme in Conjunction with External Beam Radiation Therapy
•  NCT00052208: [1112] Phase I/II Iressa + RT for treatment of previously untreated GBM.
•  * * * Duplicate ** NCT00052208: [1094] Phase I/II Study of an Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI), ZD 1839 (Iressa) with Radiation Therapy in GBM
•  NCT00049387: [1545] Tipifarnib, Temzolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
•  * * * Duplicate ** NCT00049387: [995] Tipifarnib, Temzolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
•  NCT00049127: [806] Phase I/II Trial of STI-571 (Gleevec) in Patients With Recurrent Malignant Gliomas
•  * * * Duplicate ** NCT00049127: [810] Phase I/II Study of Imatinib Mesylate (Gleevec ) in Patients With Recurrent Oligodendroglioma or Mixed Oligoastrocytoma
•  NCT00047320: [614] Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors
•  NCT00047281: [1281] Pilot study of Oral Thalidomide plus Cyclophosphamide for children with recurrent or progressive brain tumors.
•  NCT00047073: [1537] Sirolimus in Treating Patients With Glioblastoma Multiforme
•  NCT00045708: [1034] Phase I/II Trial of Ixabepilone (BMS-247550) for Treatment of Patinets with Recurrent High Grade Gliomas
•  NCT00042991: [977] Phase II Study of Gefitinib and Brain Irradiation in Children With Newly Diagnosed Brain Stem Tumors or Incompletely Resected Supratentorial Malignant Gliomas
•  * * * Duplicate ** NCT00042991: [991] Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas
•  NCT00042367: [19] Study of Systemic and Spinal Chemotherapy Followed by Radiation for Infants with Brain Tumors
•  NCT00039572: [874] A Phase I/II Trial of Neutron Capture Therapy (NCT) for Glioblastoma Multiforme and Intracranial Melanoma
•  * * * Duplicate ** NCT00039572: [1479] Boron Neutron Capture Therapy in Treating Patients With Glioblastoma Multiforme or Melanoma Metastatic to the Brain
•  NCT00039468t: [1351] Thalidomide and Irinotecan in Treating Patients With Glioblastoma Multiforme Who Have Undergone Radiation Therapy
•  NCT00039468: [1352] Thalidomide and Irinotecan in Treating Patients With Glioblastoma Multiforme Who Have Undergone Radiation Therapy
•  NCT00039364: [1025] Open Label Phase II Study on STI571 Administered As a daily Oral Treatment In Gliomas
•  NCT00038441: [797] Phase I/II Study of Intratumoral Injection of DTI-015 Prior to Tumor Resection in Patients with Recurrent Malignant Glioma or Metastatic Neoplasm to Brain
•  NCT00036972: [1140] Phase I Study of Continuous Intracerebral Infusion of Interleukin-13 PE38QQR Immunotoxin Before and After Second Resection in Patients With Recurrent Resectable Supratentorial Malignant Glioma
•  NCT00033254: [1111] A Phase III Study of Conventional Radiation Therapy Plus Thalidomide Versus Conventional Radiation Therapy For Multiple Brain Metastases
•  * * * Duplicate ** NCT00033254: [1098] A Phase III Study of Conventional Radiation Therapy Plus Thalidomide Versus Conventional Radiation Therapy For Multiple Brain Metastases
•  NCT00032097: [1033] Phase I Trial to Evaluate Repetitive Intravenous Doses of Gadolinium-Texaphyrin as a Radiosensitizer in Patients with Glioblastoma Multi Forme
•  * * * Duplicate ** NCT00032097: [1060] Phase I Trial to Evaluate Repetitive Intravenous Doses of Gadolinium-Texaphyrin as a Radiosensitizer in Patients with Glioblastoma Multiforme
•  NCT00031798: [1118] Immediate release methylphenidate, sustained release methylphenidate and modafinil for brain tumor patients undergoing chemotherapy
•  * * * Duplicate ** NCT00031798: [579] The Effect of Methylphenidate on Neurobehavioral Slowing and Quality of Life in Patients with Metastatic or Primary Brain Tumors Recieving Radiation Therapy
•  NCT00031083: [334] Phase 2 Trial Of Recombinant Human Interferon Beta In The Treatment Of Patients With Recurrent Glioma
•  * * * Duplicate ** NCT00031083: [931] Phase 1 trial of IFN-Beta Gene Transfer in the Treatment of Glioblastoma Multiforme
•  NCT00030628: [981] A Phase III Randomized Trial of the Role of Whole Brain Radiation Therapy in Addition to Radiosurgery in the Management of Patients with One to three Cerebral Metastases
•  * * * Duplicate ** NCT00030628: [1309] Z0300: Phase III Randomized Trial of the Role of Whole Brain Radiation Therapy in Addition to Radiosurgery in the Management of Patients with One to Three Cerebral Mets
•  * * * Duplicate ** NCT00030628: [959] A Phase III Randomized Trial of the Role of Whole Brain Radiation Therapy in Addition to Radiosurgery in patients with One to Three Cerebral Metastasis
•  * * * Duplicate ** NCT00030628: [1019] A Phase II Randomized Trial of the Role of Whole Brain Radiation Therapy in Addition to radiosurgery in the Management of Patients with One to Three Cerebral Metastases
•  * * * Duplicate ** NCT00030628: [186] Phase 2 Study of Radiosurgery as an Adjunct to External Radiation for the Treatment of Patients With Newly Diagnosed Metastatic Brain Tumor
•  NCT00029523: [1065] A Randomized Clinical Study to Determine the Patient Benefit and Safety of Depocyt (Cytarabine Liposome Injection) for the Treatment of Neoplastic Meningitis
•  * * * Duplicate ** NCT00029523: [349] Phase 4 Multi-Center Clinical Study Of Depofoam Encapsulated Cytoarabine In The Treatment Of Neoplastic Meningitis In Patients With Solid Tumors, Including Primary Brain Tumors
•  * * * Duplicate ** NCT00029523: [866] HCI 8609-01 randomized study of Depocyte for treatment of neoplastic meningits
•  NCT00028795: [1103] Phase II Pilot Study of Adjuvant Temozolomide Concurrently With Postoperative Radiotherapy and Then Alone As Maintenance Therapy in Children With Newly Diagnosed Anaplastic Astrocytoma, Glioblastoma Multiforme, Gliosarcoma, or Diffuse Intrinsic Pontine Glioma
•  * * * Duplicate ** NCT00028795: [164] Protocol for newly diagnosed patients aged 6 to 60 years with glioblastoma multiforme or diffuse intrinsic pontine tumors (non-biopsied or grades 3-4), anaplastic astrocytoma, following initial irradiation, using myeloblative chemotherapy (Thiotepa, Carboplatin) and stem cell rescue.
•  * * * Duplicate ** NCT00028795: [1086] A Phase II Study of Temozolomide in the Treatment of Children With High-Grade Gliomas
•  * * * Duplicate ** NCT00028795: [1492] Chemotherapy and Radiation Therapy After Surgery in Treating Children With Newly Diagnosed Astrocytoma, Glioblastoma Multiforme, Gliosarcoma, or Diffuse Intrinsic Pontine Glioma
•  * * * Duplicate ** NCT00028795: [1547] Phase II Pilot Study of Adjuvant Temozolomide Concurrently With Postoperative Radiotherapy and Then Alone As Maintenance Therapy in Children With Newly Diagnosed Anaplastic Astrocytoma, Glioblastoma Multiforme, Gliosarcoma, or Diffuse Intrinsic Pontine Glioma
•  NCT00028678: [1066] A Phase II Study to Evaluate the Effect of Dalteparin and Radiation Therapy on Survival Compared to the RTOG RPA Database and on Thromboembolic Events in Patients with Newly Diagnosed Glioblastoma Multiforme
•  NCT00027846: [1087] Phase II Study of Conformal Radiotherapy For Pediatric Patients With Localized Ependymoma, Chemotherapy Prior to Second Surgery in Pediatric Patients With Incompletely Resected Ependymoma, and Observation Only in Pediatric Patients With Completely Resected Differentiated, Supratentorial Ependymoma
•  NCT00027625: [949] NABTC 0102: A Phase I study of ZD 1839 (Gefitinib) and Temozolomide for the Treatment of Gliomas
•  * * * Duplicate ** NCT00027625: [964] Gefitinib Plus Temozolomide in Treating Patients With Malignant Primary Glioma
•  NCT00027612: [1478] Irinotecan Plus Radiation Therapy Followed By Chemotherapy in Treating Patients With Glioblastoma Multiforme
•  NCT00025675: [1570] Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors
•  * * * Duplicate ** NCT00025675: [963] ZD1839 for Treatment of Recurrent or Progressive Malignant Astrocytoma or Glioblastoma and Recurrent or Progressive Meningioma: A Phase II Study with a Phase I Component for Patients Receiving EIAEDs
•  * * * Duplicate ** NCT00025675: [944] NABTC 0001: ZD1839 for Treatment of Recurrent or Progressive Malignant Astrocytoma or Glioblastoma and Recurrent or Progressive Meningioma: A Phase II Study with a Phase I Component for Patients Receiving EIAEDs.
•  * * * Duplicate ** NCT00025675: [948] NABTC 0001: ZD 1839 for Treatment of Recurrent or Progressive Malignant Astrocytoma or Glioblastoma and Recurrent or Progressive Meningioma: A Phase II Study with a Phase I component for Patients Receiving EIAEDs
•  NCT00025558: [30] Intensive Chemotherapy with Autologous Bone Marrow Transplant or Stem Cell Rescue (Plus Focal Radiotherapy for Ages >3 Years Old) for Pediatric Anaplastic Astrocytoma, Glioblastoma Multiforme and High Risk PNETs.
•  NCT00022724: [950] NABTC 01-01: A Phase I/II Trial of CCI-779 in Patients with Malignant Gliomas
•  * * * Duplicate ** NCT00022724: [879] Phase I/II Trial of CCI-779 in Patients With Malignant Gliomas.
•  * * * Duplicate ** NCT00022724: [965] Phase I/II Trial of CCI-779 in Patients with Malignant Glioma
•  NCT00021229: [1274] Phase I/II study trial of STI571 (Gleevec) in children with newly diagnosed, poor prognosis brainstem gliomas and recurrent intracranial malignant gliomas.
•  NCT00019058: [384] Phase I Study of Combined Radiation Response Modifiers Employing Hydroxyurea and Pentoxifylline for Treatment of Glioblastoma
•  NCT00017264: [1074] Phase I Evaluation of the Safety & Pharmacokinetics of Atrasentan in Adults with Recurrent Malignant Gliomas
•  * * * Duplicate ** NCT00017264: [1037] Phase I Evaluation of the Safety and Pharmacokinectics of Asrasentan in Adults with Recurrent Malignant Gliomas.
•  NCT00017147: [1113] Phase III O6 BG/BCNU + RT vs. BCNU + RT for treatment of GBM
•  NCT00015899: [1273] Phase I study of SCH 66336 in pediatric patients with recurrent or progressive poor prognosis brain tumors.
•  NCT00014677: [766] Phase II Study of Interleukin-4(38-37)-PE38KDEL Cytotoxin (NBI-3001) Followed by Surgical Resection in Patients With Recurrent Glioblastoma Multiforme
•  * * * Duplicate ** NCT00014677: [333] Phase II Study of Interleukin-4(38-37)-PE38KDEL Cytotoxin (NBI-3001) Followed by Surgical Resection in Patients With Recurrent Glioblastoma Multiforme
•  NCT00014521: [1101] Phase I Study of Karenitecin in Patients With Recurrent Malignant Glioma
•  * * * Duplicate ** NCT00014521: [1248] Phase II treatment with Karenitecin for adults with primary malignant glioma.
•  * * * Duplicate ** NCT00014521: [1036] Phase I Evaluation ofo the Safety of Karenitecin in the treatment of Recurrent Malignant Gliomas
•  * * * Duplicate ** NCT00014521: [1073] Phase I Evaluation of the Safety of Karenitecin in the Treatment of Recurrent Malignant Gliomas
•  NCT00014443: [1552] Topotecan and Thalidomide in Treating Patients With Recurrent or Refractory Malignant Glioma
•  NCT00012038: [1039] A Phase I/II Trial of the MG1114 for Treatment of Patients with Recurrent Malignant Gliomas
•  NCT00010049: [900] NABTC 9908 A Phase I/II Trial of STI571(Imatinib Mesylate ) (NSC716051) in Patients with Recurrent Malignant Gliomas
•  * * * Duplicate ** NCT00010049: [801] Phase I/II Trial of STI571 (Gleevec) (NSC 716051) in Patients with Recurrent Malignant Gliomas
•  NCT00008008 (Duplicate): [1565] Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Malignant Glioma
•  NCT00006773: [1651] Bortezomib in Treating Patients With Recurrent Glioma
•  NCT00006386: [905] RTOG 0023 A Phase II Trial of Accelerated Radiotherapy Using Weekly Stereotactic Conformal Boosts for Supratentorial Glioblastoma Multiforme.
•  NCT00006358: [1011] Daily low-dose temozolomide plus thalidomide for patients with recurrent gliomas
•  NCT00006355: [1032] Phase I/II Study of Pyrazoloacridine (PZA) in Adults with Newly diagnosed Glioblastoma Multiforme
•  * * * Duplicate ** NCT00006355: [742] NABTT Trial: Phase I/II Study of Pyraxolacridin (PZA) in Adults with Newly Diagnosed Glioblastoma Multiforme
•  * * * Duplicate ** NCT00006355: [813] Phase I/II Study of Pyrazoloacridine (PZA) in Adults with Newly Diagnosed Glioblastoma Multiforme.
•  * * * Duplicate ** NCT00006355: [847] A Phase I/II Study of Pyrazoloacridine (PZA) in Adults with Newly Diagnosed Malignant Glioma
•  NCT00006268: [1028] Interstitial Infusion of IL-13 Pe38QQR Cytoxin in Recurrent Malignant Glioma: Phase I/II Sstudy
•  NCT00006263: [935] Carboplatin, Temozolomide, and Filgrastim in Treating Patients With Newly Diagnosed or Recurrent High-Grade Glioma
•  NCT00006238: [550] Phase I/II Evaluation of Phenylbutyrate in Adults with Recurrent Malignant Gliomas
•  NCT00006102: [1105] A Phase II trial of Rebeccamycin Analogue (NSC# 655649) in Children with Solid Tumors
•  * * * Duplicate ** NCT00006102: [786] A Phase II trial of Rebeccamycin Analogue (NSC# 655649) in Children with Solid Tumors
•  NCT00006093: [820] NABTT 9911 A Phase I/II Trial of EMD 121974 for Treatment of Patients with Recurrent Malignant Gliomas
•  * * * Duplicate ** NCT00006093: [849] A Phase I/II Trial of EMD 121974 for Treatment of Recurrent Malignant Gliomas
•  * * * Duplicate ** NCT00006093: [1041] Phase I/II Trial of EMD 121974 for TX of Pt`s with Recurrent Anaplastic Gliomas.
•  NCT00006080: [764] A Phase II Evaluation of Fenretinide(NSC 37455) as a Single Agent in the Treatment of Adult Patients with Recurrent Malignant Glioma.
•  NCT00006067: [765] Phase I/II Trial of SU5416 in Patients With Recurrent High Grade Astrocytomas or Mixed Gliomas. (e.g. Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma)
•  NCT00006025: [789] NABTC:99-07 A Phase I/II Trial of CPT-11 and Temozolomide in Patients with Recurrent Malignant Glioma
•  * * * Duplicate ** NCT00006025: [856] CPT-11 and Temozolomide (Temodar) in Patients with Recurrent Malignant Glioma
•  * * * Duplicate ** NCT00006025: [901] NABTC 9907 A Phase I/II Trial of CPT-11 and Temozolomide in patients with recurrent glioma
•  NCT00006024: [938] A Phase I Study of Temozolomide and CCNU in Pediatric Patients with newly diagnosed Incompletely Resected Non-Brainstem High Grade Gliomas
•  NCT00005951: [1247] Phase I treatment with Irinotecan (CPT-11) plus Temodar for adults with primary malignant glioma.
•  NCT00005859: [903] A Phase I/II Trial of R115777 in Patients with Recurrent Malignant Glioma
•  * * * Duplicate ** NCT00005859: [733] Phase I/II Trial of R115777 in Patients with Recurrent Malignant Gliomas
•  * * * Duplicate ** NCT00005859: [888] R115777 IN PATIENTS WITH RECURRENT MALIGNANT GLIOMA
•  NCT00005856: [1099] Phase I/II Trial of Oxaliplatin as Neoadjuvant TX in adults newly diagnosed GBM
•  NCT00005855: [819] Phase I/II Study of Efaproxiral and Carmustine in Patients With Progressive or Recurrent High-Grade Gliomas
•  * * * Duplicate ** NCT00005855: [1551] Efaproxiral Plus Carmustine in Treating Patients With Progressive or Recurrent Malignant Glioma
•  NCT00005812: [865] Temozolomide in Treating Patients With Leptomeningeal Metastases From a Solid Tumor or Lymphoma
•  NCT00005602: [937] Phase I Study of Concurrent Cereport and Carboplatin with Radiation Therapy for Children with Newly Diagnosed Brain Stem Gliomas
•  NCT00004892: [816] Phase I Study of Polifeprosan 20 With Carmustine Implants (Gliadel Wafers) and O6-Benzylguanine in Patients With Recurrent Malignant Glioma
•  NCT00004259: [864] SWOG (RTOG) 98-13 randomized trial of RT + Temozolomide vs RT + BCNU, versus RT+ Tem + BCNU
•  * * * Duplicate ** NCT00004259: [1062] Phase I/II Randomized Study of Radiation Therapy and Temozolomide Versus Radiation Therapy and BCNU Versus Radiation Therapy and Temozolomide and BCNU for Anaplastic Astrocytoma
•  * * * Duplicate ** NCT00004259: [906] RTOG 9813 A Phase I/III Randomized Study of Radiation Therapy and Temozolomide versus Radiation Therapy and BCNU versus Radiation Therapy and Temozolomide and BCNU for Anaplastic Astrocytoma.
•  NCT00004200: [723] A randomized double blind placebo controlled phase II study of the matrix metalloproteinase inhibitor prinomastat in combination with temozolomide following radiation therapy in patients with newly diagnosed glioblastoma multiforme.
•  NCT00004147: [850] A Phase I/II Study Of Col-3 Administered on a Continuous Daily Oral Schedule in Patients with High Grade Astrocytoma
•  * * * Duplicate ** NCT00004147: [821] NABTT9809 A Phase I/II Study of Col-3 Administered on a Continurous Daily Oral Schedule in Patients with Recurrent High-Grade Astrocytoma
•  NCT00004129: [585] Phase I Study of Interstitial Colloidal Phosphorus P32 in Patients With Recurrent or Poor Prognosis Grade 4 Astrocytoma
•  NCT00004078: [613] A Phase II Trial of Irinotecan (CPT-11) in Children with Refractory Solid Tumors.
•  NCT00004073: [595] Phase II Study of Suramin and Concurrent Radiation Therapy in Newly Diagnosed GBM
•  NCT00004041: [805] Gene Therapy for Recurrent Gliomas
•  * * * Duplicate ** NCT00004041: [736] Phase I Trial of Adenovirus-Mediated Wild Type p53 Gene Therapy for Maligant Glioma
•  NCT00004028: [379] Phase I Open-Label, Multicenter Study of Intraoperative Implantation of Polifeprosan 20 Wafers Containing Carmustine (GLIADEL) for Recurrent Malignant Glioma
•  NCT00004024: [132] Phase 1/2 Study of Monoclonal Antibody (OKT-3) And Cyclophosphamide in Patients With Advanced Brain Tumors.
•  NCT00004017: [860] Radiolabeled Monoclonal Antibody in Treating Patients With Glioblastoma Multiforme or Anaplastic Astrocytoma
•  * * * Duplicate ** NCT00004017: [358] Utilization Of Iodine-125 Monoclonal Antibody In The Treatment Of Primary Glioblastoma Multiforme And Anaplastic Astrocytoma
•  NCT00004015: [1627] Boron Neutron Capture Therapy Following Surgery in Treating Patients With Glioblastoma Multiforme Removed During Surgery
•  NCT00004004: [741] NABTT Study: A phase I/II Trial of Oral Procarbazine in the Treatment of Reucrrent High Grade Astrocytomas
•  * * * Duplicate ** NCT00004004: [594] A Phase I/II study of oral procarbazine in treatment of recurrent high grade astrocytoma
•  * * * Duplicate ** NCT00004004: [848] A Phase I/II Study of Oral Procarbazine in the Treatment of Recurrent High Grade Astrocytomas
•  NCT00003916: [884] A Phase II Trial of Accelerated Radiotherapy using weekly sterotactic conformal boosts for supratentorial glioblastoma multiforme
•  NCT00003909: [609] A Phase I Study of Motexafin Gadolinium and Involved Field Radiation Therapy for Intrinsic Pontine Glioma of Childhood
•  NCT00003878: [532] Phase II Trial of Surgery with Gliadel Wafer and Radiation in Patients with Operable CNS Metastases from Systemic Cancer
•  * * * Duplicate ** NCT00003878: [515] Gliadel wafer for the treatment of metastatic brain tumors
•  NCT00003876: [110] Phase 3 Randomized Evaluation of Adding Interstitial Radiotherapy With 125I to External Beam Irradiation + BCNU Following Surgery For Patients With Malignant Glioma
•  NCT00003846: [604] Treatment of High Risk Central Nervous System Embryonal Tumors with Conventional Radiotherapy and Intensive Consolidation Chemotherapy with Peripheral Blood Progenitor Cell (PBSC) Support
•  NCT00003775: [503] Phase 2 open label study of SU101 for patients with anaplastic astrocytoma in first relapse
•  NCT00003751: [1068] Phase II Trial of Surgical Resection, Gliadel Wafer, and Irradiation Followed by Penicillamine/Low Copper Diet for Newly Diagnosed Glioblastoma Multiforme
•  NCT00003632: [722] A phase II study of intensive methotrexate and cytarabine followed by high dose BEAM chemotherapy with autologous peripheral blood progenitor cell transplantation in patients with newly diagnosed primary central nervous system lymphoma.
•  NCT00003621: [167] Treatment of anaplastic glioma with intra-arterial cisplatin, radiotherapy and surgical resection vs. BCNU
•  NCT00003616: [737] Phase I/II Trial of Irinotecan (CPT-11) in Patients with Recurrent Malignant Glioma
•  NCT00003590: [862] SWOG 9811 Hydroxyurea for unresectable meningioma
•  * * * Duplicate ** NCT00003590: [1110] SWOG 9811 Hydroxyurea for unresectable meningioma
•  * * * Duplicate ** NCT00003590: [1132] SWOG 9811 Phase II Study of Hydroxyurea in Patients With Unresectable Benign Meningioma
•  NCT00003574: [559] A Multi-Center, Open-Label Clinical Study to Evaluate the Safety and Mechanical Performance of the GliaSite RTS, a Radiation Delivery System, in Patients with Recurrent Malignant Brain Tumors Undergoing Surgical Resection
•  * * * Duplicate ** NCT00003574: [815] Phase II Study of the Proxima GliaSite RTS, a Radiation Delivery System, in Patients with Progressive or Recurrent Malignant Brain Tumors Undergoing Surgical Resection
•  NCT00003567 (Duplicate): [1564] Gene Therapy Plus Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin`s Lymphoma
•  NCT00003567: [1581] Phase I Study of Mutant MGMT Gene Transfer Into Human Hematopoietic Progenitors to Protect Hematopoiesis During O6-Benzylguanine and Carmustine Followed by O6-Benzylguanine and Temzolomide in Patients With Advanced Solid Tumors or Non-Hodgkin`s Lymphoma
•  NCT00003478: [1254] Phase I/II study of Anti-Tenascin Monoclonal Antibody 131I-Labeled 81C6 via surgically created cystic resection cavity in the treatment of patients with malignant CNS tumors.
•  NCT00003466: [629] A Phase II Study of Temozolomide (Temodar) in the Treatment of Adult Patients with Supratentorial Low Grade Glioma
•  * * * Duplicate ** NCT00003466: [1249] Phase II treatment with Temodar for adults and children with progressive low grade gliomas.
•  NCT00003462: [1009] Intrathecal busulfan chemotherapy for patients with neoplastic meningitis (carcinomatous or lymphomatous meningitis).
•  NCT00003417: [907] RTOG 9803 Phase I/II Radiation Dose Escalation Study Applying Conformal Radiation Therapy in Supratentorial Glioblastoma Multiforme.
•  NCT00003375: [945] RTOG 9802: A Phase II Study of Observation in Favorable Low-Grade Glioma and a Phase III Study of Radiation with or without PCV Chemotherapy in Unfavorable Low-Grade Glioma
•  * * * Duplicate ** NCT00003375: [560] Observation in Favorable Low-Grade Glioma and Phase III Study of RT +/- PCV Chemo in Unfavorable Low-Grade Glioma
•  NCT00003370: [852] Irofulven in Treating Children With Recurrent or Refractory Solid Tumors
•  NCT00003324: [1230] A Phase II Study Utilizing Focal Radiation in patients With 1-3 Brain Metastases.
•  NCT00003309: [1061] Phase II Trial of Preradiation Multiagent Chemotherapy for Adults with "Poor Risk" Medulloblastoma, PNET, and Disseminated Ependymoma
•  * * * Duplicate ** NCT00003309: [1043] Combination Chemotherapy Plus Radiation Therapy in Treating Adult Patients With Brain Cancer
•  NCT00003301: [410] A Dose Finding And Safety / Efficacy Trial Of CPT-11 (Irinotecan) In Patients With Recurrent Malignant Glioma
•  NCT00003293: [510] Phase 3 randomized study of SU101 versus Procarbazine for patients with glioblastoma multiforme in first relapse.
•  * * * Duplicate ** NCT00003293: [458] Phase III Randomized Study of Leflunomide (SU101) Versus Procarbazine for Patients with Glioblastoma Multiforme in First Relapse
•  * * * Duplicate ** NCT00003293: [502] Phase 3 randomized study of SU101 vs. procarbazine for patients with glioblastoma multiforme in first relapse
•  NCT00003211: [398] Phase II Study of Cyclophosphamide Plus Topotecan In Children With Recurrent Or Refractory Solid Tumors
•  NCT00003203: [603] A group-wide pilot study of concurrent carboplatin, vincristine and radiotherapy followed by adjuvant chemotherapy in patients with newly diagnosed central nervous system embryonal tumors.
•  NCT00003185: [121] Phase 1 Study of Adoptive Cellular Immunotherapy Plus IL-2 in Patients With Recurrent High Grade Gliomas or Metastases to the Brain.
•  NCT00003141: [605] A Phase I/II group-wide pilot study of intensive chemotherapy with peripheral stem cell support for infants with malignant brain tumors.
•  NCT00003134: [488] A phase 2 trial of Irinotecon (CPT-11) in recurrent glioma
•  NCT00003073: [958] A Randomizwed clinical study to determine the Patient Benefit and Safety of DEPOCYT(Cytarabine Liposome Injection) for the Treatment of Neoplastic Meningitis
•  NCT00002986: [1252] Phase II treatment with Topotecan plus BCNU for patients with primary malignant glioma.
•  NCT00002944: [602] Chemotherapy for progressive low grade astrocytoma in children < 10 years old.
•  NCT00002882: [539] Phase 2 study of modified biochemotherapy for advanced Melanoma.
•  * * * Duplicate ** NCT00002882: [538] Phase 2 study of outpatient concurrent chemo-biotherapy (Cisplatin, Temozolomide (Temodal), IL-2 and Interferon Alpha 2b) for the treatment of metastatic malignant melanoma
•  * * * Duplicate ** NCT00002882: [533] Phase 2 pilot trial of concurrent biochemotherapy with Cisplatin, Vinblastine, Temozolomide, IL-2, and Interferon Alpha 2B in patients with metastatic malignant melanoma
•  NCT00002824: [624] Gene thereapy of malignant gliomas: A phase 1 study of IL-4 and HSV-TK gene-modified autologous tumor to elicit an immune response
•  * * * Duplicate ** NCT00002824: [327] Prospective, Open Label, Parallel Group, Randomized, Multicenter Trial Comparing The Efficacy Of Surgery, Radiation And Gene Therapy (Injection Of Murine Cells Producing Herpes Simplex Thymadine Kinase Vector Followed By IV Ganciclovir) Against the Efficacy Of Surgery And Radiation In The Treatment Of Newly Diagnosed, Previously Untreated Glioblastoma.
•  NCT00002814: [386] Phase II study of Paclitaxel/Topotecan/G-CSF for recurrent glioblastoma multiforme or anaplastic astrocytoma
•  NCT00002708: [322] Phase 3 trial comparing whole brain irradiation with versus without stereotactic radiosurgery boost for patients with 1 To 3 unresected brain metastases.
•  * * * Duplicate ** NCT00002708: [345] Phase 3 Trial Comparing Whole Brain Radiation With Vs. Without Stereotactic Radiosurgery Boost For Patients With 1 to 3 Unresected Brain Mets.
•  NCT00002619: [115] High dose chemotherapy with autologous stem cell rescue for patients aged less than 60 years with recurrent malignant brain tumors in "minimal" residual disease.
•  NCT00002569: [21] PCV (Procarbazine, CCNU, Vincristine) For The Treatment Of Recurrent Anaplastic Oligodendroglioma
•  * * * Duplicate ** NCT00002569: [264] RTOG 94-02: Phase 3 Intergroup Randomized Comparison Of radiation Alone Vs. Pre-Radiation Chemotherapy For Pure And Mixed Anaplastic Oligodendrogliomas
•  * * * Duplicate ** NCT00002569: [346] Intergroup Randomized Comparison Of Radiation Therapy Alone Vs. Pre-Radiation Therapy Chemo For Pure And Mixed Anaplastic Oligodendrogliomas
•  NCT00002545: [323] Phase 3 trial comparing the use of radiosurgery followed by conventional radiotherapy with BCNU to conventional radiotherapy with BCNU for supratentorial glioblastoma multiforme.
•  * * * Duplicate ** NCT00002545: [340] Phase 3 Trial Comparing Stereotactic External beam Irradiation Followed By Conventional Radiation Therapy With BCNU To Conventional Radiation Therapy With BCNU For Supratentorial Glioblastoma
•  NCT00001807: [727] Nuclear Magnetic Resonance Spectroscopic Imaging of the Brain in patients who receive Neurotoxicic Therapy
•  NCT00001574: [599] Pilot Study of 1H-Nuclear Magnetic Resonance Spectroscopic (NMRS) Imaging in Pediatric Patients with Primary Brain Tumors
•  06BG, BCNU: [966] SWOG S0001 Randomized trial of radiation + BCNU, +/- O6BG
•  00114140: [1908] RTOG 0424 A Phase II Study of Temozolomide-Based Chemoradiotherapy Regimen for High Risk Low-Grade Gliomas